A New and Better Treatment Improves Survival in Ovarian Cancer Patients

Print pagePDF pageEmail page

It is well known that chemotherapy can not be used in a patient for a long time due to its toxicity.  A new study indicated that patients who have stopped chemotherapy can lived longer without disease worsening by adding Avastin® (bevacizumab) to their treatment regimen

In the study (GOG 0218), 1,873 women with newly diagnosed advanced ovarian cancer who already had surgery to remove as much of the tumor as possible were randomized to receive one of the three treatment arms.

The results indicated that those patients who received Avastin in combination with chemotherapy (carboplatin plus paclitaxel), and then who also used Avastin as maintenance therapy, lived longer without the disease worsening compared to those who received chemotherapy alone.

This study will be presented at the American Society of Clinical Oncology (ASCO) annual meeting, June 4 to 8, 2010.


Visit us at healthreason.com for more articles like this.

Print Friendly
Be Sociable, Share!
This entry was posted in Cancer, Ovarian Cancer and tagged , , . Bookmark the permalink.